BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 11726964)

  • 1. Annihilating host defense.
    Frank MM
    Nat Med; 2001 Dec; 7(12):1285-6. PubMed ID: 11726964
    [No Abstract]   [Full Text] [Related]  

  • 2. Evasion of human innate and acquired immunity by a bacterial homolog of CD11b that inhibits opsonophagocytosis.
    Lei B; DeLeo FR; Hoe NP; Graham MR; Mackie SM; Cole RL; Liu M; Hill HR; Low DE; Federle MJ; Scott JR; Musser JM
    Nat Med; 2001 Dec; 7(12):1298-305. PubMed ID: 11726969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of human complement component C4b-binding protein (C4BP) to Streptococcus pyogenes involves the C4b-binding site.
    Accardo P; Sánchez-Corral P; Criado O; García E; Rodríguez de Córdoba S
    J Immunol; 1996 Dec; 157(11):4935-9. PubMed ID: 8943398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How group A Streptococcus circumvents host phagocyte defenses.
    Kwinn LA; Nizet V
    Future Microbiol; 2007 Feb; 2(1):75-84. PubMed ID: 17661677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Host-pathogen interactions in Streptococcus pyogenes infections, with special reference to puerperal fever and a comment on vaccine development.
    Areschoug T; Carlsson F; Stålhammar-Carlemalm M; Lindahl G
    Vaccine; 2004 Dec; 22 Suppl 1():S9-S14. PubMed ID: 15576204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phagocytosis.
    Stossel TP
    Prog Clin Biol Res; 1977; 13():87-102. PubMed ID: 400763
    [No Abstract]   [Full Text] [Related]  

  • 7. Ancient origin of the complement system: emerging invertebrate models.
    Pinto MR; Melillo D; Giacomelli S; Sfyroera G; Lambris JD
    Adv Exp Med Biol; 2007; 598():372-88. PubMed ID: 17892225
    [No Abstract]   [Full Text] [Related]  

  • 8. Immune evasion by a staphylococcal complement inhibitor that acts on C3 convertases.
    Rooijakkers SH; Ruyken M; Roos A; Daha MR; Presanis JS; Sim RB; van Wamel WJ; van Kessel KP; van Strijp JA
    Nat Immunol; 2005 Sep; 6(9):920-7. PubMed ID: 16086019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biologia Futura: stories about the functions of β
    Bajtay Z
    Biol Futur; 2021 Mar; 72(1):7-13. PubMed ID: 34554501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival of Streptococcus pyogenes within host phagocytic cells: a pathogenic mechanism for persistence and systemic invasion.
    Medina E; Goldmann O; Toppel AW; Chhatwal GS
    J Infect Dis; 2003 Feb; 187(4):597-603. PubMed ID: 12599076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Streptococcus pyogenes--pathogenetic factors and their involvement in the pathogenesis of acute streptococcal infections and their complications].
    Ungureanu V
    Bacteriol Virusol Parazitol Epidemiol; 1993; 38(3-4):34-47. PubMed ID: 8173211
    [No Abstract]   [Full Text] [Related]  

  • 12. Evasion of phagocytosis through cooperation between two ligand-binding regions in Streptococcus pyogenes M protein.
    Carlsson F; Berggård K; Stålhammar-Carlemalm M; Lindahl G
    J Exp Med; 2003 Oct; 198(7):1057-68. PubMed ID: 14517274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement inhibition by gram-positive pathogens: molecular mechanisms and therapeutic implications.
    Laarman A; Milder F; van Strijp J; Rooijakkers S
    J Mol Med (Berl); 2010 Feb; 88(2):115-20. PubMed ID: 20062962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Virulence of Group A Streptococci Is Enhanced by Human Complement Inhibitors.
    Ermert D; Shaughnessy J; Joeris T; Kaplan J; Pang CJ; Kurt-Jones EA; Rice PA; Ram S; Blom AM
    PLoS Pathog; 2015 Jul; 11(7):e1005043. PubMed ID: 26200783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factor H-IgG Chimeric Proteins as a Therapeutic Approach against the Gram-Positive Bacterial Pathogen
    Blom AM; Magda M; Kohl L; Shaughnessy J; Lambris JD; Ram S; Ermert D
    J Immunol; 2017 Dec; 199(11):3828-3839. PubMed ID: 29084837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Streptococcus pyogenes and phagocytic killing.
    von Pawel-Rammingen U; Johansson BP; Tapper H; Björck L
    Nat Med; 2002 Oct; 8(10):1044-5; author reply 1045-6. PubMed ID: 12357219
    [No Abstract]   [Full Text] [Related]  

  • 17. Human fibrinogen bound to Streptococcus pyogenes M protein inhibits complement deposition via the classical pathway.
    Carlsson F; Sandin C; Lindahl G
    Mol Microbiol; 2005 Apr; 56(1):28-39. PubMed ID: 15773976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct recognition of complement iC3b by integrins α
    Xu S; Wang J; Wang JH; Springer TA
    Proc Natl Acad Sci U S A; 2017 Mar; 114(13):3403-3408. PubMed ID: 28292891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Streptococcus pyogenes and human neutrophils: a paradigm for evasion of innate host defense by bacterial pathogens.
    Voyich JM; Musser JM; DeLeo FR
    Microbes Infect; 2004 Oct; 6(12):1117-23. PubMed ID: 15380782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The phagocytic process and the role of complement in host defense.
    Verhoef J
    J Chemother; 1991 Jan; 3 Suppl 1():93-7. PubMed ID: 12041798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.